Skip to main content

Polarityte, Inc.

PTEDelisted Jul 10, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001076682

Polarityte, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jan 30, 2023; 46 institutions reported holding it in 13F filings for Q1 2022, worth $4.01M in total; no superinvestor held it.

Holders of 5% or more of PTE

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Polarityte, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Polarityte, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

5 Schedule 13D and 13G filings on Polarityte, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on PTE
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 14, 2023Honig Jonathan13G/AOld format–––SEC
Aug 23, 2022Honig Jonathan13GOld format–New–SEC
Feb 16, 2021Armistice Capital, LLC13GOld format–New–SEC
Feb 11, 2021Honig Barry C13G/AOld format–––SEC
Jan 12, 2021Gatemore Capital Management LLP13D/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Polarityte, Inc. shares.

No Form 144 notices for Polarityte, Inc. are on file.